Genetron Holdings Limited (NASDAQ:GTH – Get Free Report) shot up 0.2% on Monday . The stock traded as high as $4.05 and last traded at $4.03. 412,600 shares traded hands during mid-day trading, an increase of 699% from the average session volume of 51,662 shares. The stock had previously closed at $4.02.
Genetron Price Performance
The company has a 50-day moving average price of $3.96 and a two-hundred day moving average price of $3.80.
Institutional Investors Weigh In On Genetron
An institutional investor recently bought a new position in Genetron stock. Crystalline Management Inc. purchased a new position in shares of Genetron Holdings Limited (NASDAQ:GTH – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 113,395 shares of the company’s stock, valued at approximately $417,000. Crystalline Management Inc. owned about 0.36% of Genetron as of its most recent SEC filing. Institutional investors own 10.74% of the company’s stock.
Genetron Company Profile
Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services.
Featured Stories
- Five stocks we like better than Genetron
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- High-Yield Texas Instruments Could Hit New Highs Soon
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What is a Special Dividend?
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Genetron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genetron and related companies with MarketBeat.com's FREE daily email newsletter.
